These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 9083707)
41. The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines. Gillman S; Gillard M; Strolin Benedetti M Allergy Asthma Proc; 2009; 30(4):366-76. PubMed ID: 19335943 [TBL] [Abstract][Full Text] [Related]
42. Nonsedating H1 antihistamines in chronic urticaria. Monroe EW Ann Allergy; 1993 Dec; 71(6):585-91. PubMed ID: 7903515 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of the optimal oral antihistamine for patients with allergic rhinitis. Meltzer EO Mayo Clin Proc; 2005 Sep; 80(9):1170-6. PubMed ID: 16178497 [TBL] [Abstract][Full Text] [Related]
48. Allergic rhinitis in family practice: the role of levocetirizine in clinical care. Bukstein DA; Lapine TJ Postgrad Med; 2008 Jul; 120(2):101-10. PubMed ID: 18654075 [TBL] [Abstract][Full Text] [Related]
50. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Ng KH; Chong D; Wong CK; Ong HT; Lee CY; Lee BW; Shek LP Pediatrics; 2004 Feb; 113(2):e116-21. PubMed ID: 14754980 [TBL] [Abstract][Full Text] [Related]
51. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects. Kaliner MA Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437 [TBL] [Abstract][Full Text] [Related]
52. Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Kay GG; Harris AG Clin Exp Allergy; 1999 Jul; 29 Suppl 3():147-50. PubMed ID: 10444229 [TBL] [Abstract][Full Text] [Related]
53. Results obtained with Loderix tablet in chronic rhinitis patients. Hirschberg A; Ribári O; Krasznai M Ther Hung; 1989; 37(4):202-4. PubMed ID: 2576575 [TBL] [Abstract][Full Text] [Related]
54. Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis. Sullivan PW; Follin SL; Nichol MB Pharmacoeconomics; 2004; 22(14):929-42. PubMed ID: 15362929 [TBL] [Abstract][Full Text] [Related]
55. New H1/H3 antagonists for treating allergic rhinitis: WO2010094643. Norman P Expert Opin Ther Pat; 2011 Mar; 21(3):425-9. PubMed ID: 21342057 [TBL] [Abstract][Full Text] [Related]
56. Safety profile of bilastine: 2nd generation H1-antihistamines. Scaglione F Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729 [TBL] [Abstract][Full Text] [Related]
57. Treating allergic rhinitis in pregnancy. Safety considerations. Mazzotta P; Loebstein R; Koren G Drug Saf; 1999 Apr; 20(4):361-75. PubMed ID: 10230583 [TBL] [Abstract][Full Text] [Related]
58. Therapeutic approaches to allergic rhinitis: treating the child. Fireman P J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 2):S616-21. PubMed ID: 10856167 [TBL] [Abstract][Full Text] [Related]
59. [Oral second generation antihistamines in allergic rhinitis]. Riechelmann H Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976 [TBL] [Abstract][Full Text] [Related]
60. Levocetirizine (Xyzal) for allergic rhinitis and urticaria. Med Lett Drugs Ther; 2007 Dec; 49(1275):97-9. PubMed ID: 18046285 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]